Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Thrombosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Thrombosis
    Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty - (N Engl J Med)
    Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty - (N Engl J Med)
    Extended-Use Rivaroxaban Effectively Prevents Venous Thromboembolism After Hip Surgery - (DGNews)
    Drug-Eluting Stents May Decrease Repeat Revascularisation - (DGNews)
    International Panel Agrees on Guidelines for Preventing Thrombosis in Special Patient Groups - (DGNews)

    News archive

     Recent webcasts/CME - Thrombosis
    • Background: Prevention and Management of Venous Thromboembolism in Patients with Cancer: A Case-Based Approach
    • Case Study 1: 62-Year-Old Woman With Stage IV Breast Cancer and Repeated Courses of Chemotherapy
    • Case Study 2: 64-Year-Old Man With Stage III Colorectal Cancer Who Is Scheduled for Surgery
    • Long-Term Effects on Arterial Healing with DES
      Venous Thromboembolism and Acute Coronary Syndrome: Community Pharmacists' Key Position in the Continuum of Care

      Webcasts/CME archive

       Recent cases - Thrombosis
        Sigmoid Sinus Thrombosis Presenting with Posterior Alexia in a Patient with Behcet's Disease And Polycythaemia: A Case Report
        Left Atrial Giant Thrombus Infected by Escherichia Coli. Case Report
        Middle Bile Duct Cancer with Portal Vein Tumor Thrombus
        Pleural Mesothelioma and Venous Thrombosis: The Eosinophilia Link
        Elevated Maternal Lipoprotein (A) and Neonatal Renal Vein Thrombosis: A Case Report

        Cases archive
          




        my personal edition > thrombosis > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Outpatient D-dimer Test Can Exclude Deep Venous Thrombosis

        A DGReview of :"Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients"
        American Journal of Medicine

        06/28/2002
        By Anne MacLennan


        A semiquantitative D-dimer test has been found to have high sensitivity and negative predictive value in exclusion of deep venous thrombosis.

        The finding has some exceptions, however, suggests this study from The Netherlands.

        Test sensitivity is lower in people using oral anticoagulants. Also, D-dimer tests are usually positive and thus may not be worthwhile in people with cancer and in patients more than 70 years of age.

        The D-dimer test is used commonly in diagnostic strategies to reduce the need for ultrasonography in patients suspected of having deep venous thrombosis.

        In this retrospective cohort study, Roger E.G. Schutgens and colleagues from St. Antonius Hospital, Nieuwegein, and University Hospital, Utrecht, examined several clinical and laboratory variables that might limit the accuracy of a semiquantitative D-dimer test.

        Participants were 704 outpatients suspected of having deep venous thrombosis, all of whom underwent the semiquantitative D-dimer test and ultrasonography.

        Researchers calculated the performance of the test in 61 patients using anticoagulants, 117 patients with previous thrombosis and 47 patients with malignancy, including 39 patients with more than one of these characteristics. The remaining patients were considered to be the reference group.

        Two hundred and fifty four patients (36 percent) showed evidence of deep venous thrombosis.

        In the reference group, the D-dimer test had a sensitivity of 99 percent and a negative predictive value of 98 percent. In patients on oral anticoagulants, however, test sensitivity was only 75 percent.

        Although sensitivity was 96 percent in patients with previous thrombosis and 100 percent in patients with cancer, 97 percent (553) of all patients, including 43 of the cancer patients (91 percent), had an abnormal D-dimer test.
        American Journal of Medicine Volume 112, Issue 8 Pages 617-621 "Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send